These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8109847)

  • 81. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis.
    Pham SM; Shears LL; Kawaharada N; Li S; Venkataramanan R; Sehgal S
    Transplant Proc; 1998 Jun; 30(4):953-4. PubMed ID: 9636385
    [No Abstract]   [Full Text] [Related]  

  • 82. Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation.
    Homma M; Damoiseaux JG; van Breda Vriesman PJ
    Transplant Proc; 1997 May; 29(3):1743-4. PubMed ID: 9142256
    [No Abstract]   [Full Text] [Related]  

  • 83. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Ann N Y Acad Sci; 1993 Jun; 685():121-2. PubMed ID: 8363216
    [No Abstract]   [Full Text] [Related]  

  • 84. The synergistic effects of cyclosporine and sirolimus.
    Kahan BD
    Transplantation; 1997 Jan; 63(1):170. PubMed ID: 9000684
    [No Abstract]   [Full Text] [Related]  

  • 85. Quilty effect in heterotopic cardiac allografts in malononitrilamide-treated rats.
    Slauson S; Billingham ME; Silva HT; Wang Y; Morris RE
    J Heart Lung Transplant; 1999 Dec; 18(12):1251-3. PubMed ID: 10612388
    [No Abstract]   [Full Text] [Related]  

  • 86. The synergistic effects of cyclosporine and sirolimus (reply).
    Andoh TF; Bennett WM
    Transplantation; 1997 Jun; 63(11):1703-4. PubMed ID: 9197373
    [No Abstract]   [Full Text] [Related]  

  • 87. Immunosuppressive property of Rifampicin antagonizes the beneficial effect of blood transfusion in rat organ allografting.
    Schwartz J; Charpentier B; Lang P; Martin B; Fries D
    Transplantation; 1982 Sep; 34(3):155-6. PubMed ID: 6753271
    [No Abstract]   [Full Text] [Related]  

  • 88. Rapamycin: a novel immunosuppressive macrolide.
    Sehgal SN; Molnar-Kimber K; Ocain TD; Weichman BM
    Med Res Rev; 1994 Jan; 14(1):1-22. PubMed ID: 8309312
    [No Abstract]   [Full Text] [Related]  

  • 89. Immunosuppressive profile of rapamycin.
    Sehgal SN
    Ann N Y Acad Sci; 1993 Nov; 696():1-8. PubMed ID: 8109822
    [No Abstract]   [Full Text] [Related]  

  • 90. Failure to confirm the prolonged survival of rat kidney allografts perfused with concanvalin A.
    Downing TP; Coleman DA; Steinmuller D
    Transplantation; 1978 May; 25(5):283-4. PubMed ID: 349806
    [No Abstract]   [Full Text] [Related]  

  • 91. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.
    Kahan BD; Chang JY; Sehgal SN
    Transplantation; 1991 Aug; 52(2):185-91. PubMed ID: 1871787
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Studies of tumor implants in immunologically privileged sites.
    Wajsman Z; Williams P; McGarry M; Murphy GP
    J Surg Oncol; 1980; 14(1):73-81. PubMed ID: 6247580
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of retinoid therapy on rat cardiac allograft survival.
    Kelly GE
    Transplantation; 1987 Sep; 44(3):451-3. PubMed ID: 3307065
    [No Abstract]   [Full Text] [Related]  

  • 94. Effect of lambda-carrageenan on the survival of rat heart transplants.
    Everson NW; Stacey RL; Bell PR
    Transplantation; 1977 Nov; 24(5):393-4. PubMed ID: 335595
    [No Abstract]   [Full Text] [Related]  

  • 95. Osmotic pump delivery of rapamycin.
    Di Joseph JF; Russo RJ; Cochran DW
    Transplantation; 1993 Feb; 55(2):450-2. PubMed ID: 8434406
    [No Abstract]   [Full Text] [Related]  

  • 96. Interaction of diltiazem and rapamycin on survival of rat cardiac allografts.
    Dumont L; Chen H; Xu D; Daloze P
    Ann N Y Acad Sci; 1993 Nov; 696():392-5. PubMed ID: 8109847
    [No Abstract]   [Full Text] [Related]  

  • 97. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 98. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
    Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
    [No Abstract]   [Full Text] [Related]  

  • 99. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract]   [Full Text] [Related]  

  • 100. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.